Molecular Approaches to Developing a Vaccine for Leprosy

  • Vijay Mehra
  • Robert L. Modlin
  • Thomas H. Rea
  • William R. Jacobs
  • Scott B. Snapper
  • Jacinto Convit
  • Barry R. Bloom
Conference paper
Part of the Progress in Vaccinology book series (VACCINOLOGY, volume 2)


Leprosy, a chronic infectious disease afflicting 10 million to 15 million people, is caused by the obligate intracellular parasite Mycobacterium leprae. Although M. leprae was the first identified bacterial pathogen of man, it remains one of the few human pathogens that cannot yet be grown in culture. The inability to grow leprosy bacillus in culture has severely limited the understanding of the bacillus and the disease.


Suppressor Cell Protective Antigen Lepromatous Leprosy Mycobacterium Leprae Obligate Intracellular Parasite 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Abou-Zeid C, Filley E, Steele J, Rook GAW: A simple new method for using antigens separated by Polyacrylamide gel electrophoresis to stimulate lymphocytes in vitro after converting bands cut from Western blots into antigen- bearing particles. J Immunol Methods 1987; 98: 5–10.PubMedCrossRefGoogle Scholar
  2. 2.
    Bloom BR, Godal T: Selective primary helath care: strategies for control of disease in the developing world. V. Leprosy. Rev Infect Dis 1983; 5: 765–780.PubMedCrossRefGoogle Scholar
  3. 3.
    Bloom BR, Mehra V: Immunological unresponsiveness in leprosy. Immunol Rev 1984; 80: 5–28.PubMedCrossRefGoogle Scholar
  4. 4.
    Buchanan TM, Nomaguchi H, Anderson DC, et al: Characterization of antibody-reactive epitopes on the 65-kilodalton protein of Mycobacterium leprae. Infect Immun 1987; 55: 1000–1003.PubMedGoogle Scholar
  5. 5.
    Chaudhuri S, Fotedar AR, Talwar GP: Lepromin conversion in repeatedly lepromin negative BL/LL patients after immunization with autoclaved Mycobacterium w. Int J Lepr 1983; 51: 159–168.Google Scholar
  6. 6.
    Convit J, Aranzazu N, Ulrich M, et al: Immunotherapy with a mixture of Mycobacterium leprae BCG in different forms of leprosy and in Mitsuda-negative contacts. Int J Lepr 1982; 50: 415–424.Google Scholar
  7. 7.
    Deo MG, Bapat CV, Chullawalla RG, Bhatki WS: Potential anti leprosy vaccine from killed ICRC bacilli-clinicopathological study. Indian J Med Res 1981; 74: 164–177.PubMedGoogle Scholar
  8. 8.
    DeVries RRP, Ottenhoff THM, Shuguang L, Young RA: HLA class II restricted helper and suppressor clones reactive with Mycobacterium leprae. Lepr Rev 1986; 57 (suppl. 2): 113–121.PubMedGoogle Scholar
  9. 9.
    Emmrich F, Thole J, van Embden J, Kaufmann SHE: A recombinant 64 kil- odalton protein of Mycobacterium bovis BCG specifically stimulates human T4 clones reactive to mycobacterial antigens. J Exp Med 1986; 163: 1024–1029.PubMedCrossRefGoogle Scholar
  10. 10.
    Engers HD, Abe M, Bloom BR, et al: Workshop: results of a World Health Organization-sponsored workshop on monoclonal antibodies to Mycobacterium leprae. Infect Immun 1985; 48: 603–605.Google Scholar
  11. 11.
    Fine PEM: The role of BCG in the control of leprosy. Ethiop Med J 1985; 23: 179–191.Google Scholar
  12. 12.
    Gillis TP, Buchanan TM: Production and partial characterization of monoclonal antibodies to Mycobacterium leprae. Infect Immun 1982; 37: 172–178.PubMedGoogle Scholar
  13. 13.
    Hunter SW, Fugiwara T, Brennan PJ: Structure and antigenicity of the major specific glycolipid antigen of Mycobacterium leprae. J Biol Chem 1982; 257: 15072–15078.PubMedGoogle Scholar
  14. 14.
    Jacobs WR, Tuckman M, Bloom BR: Introduction of foreign DNA into mycobacteria using a shuttle phasmid. Nature 1987; 327: 532–535.PubMedCrossRefGoogle Scholar
  15. 15.
    Lamb JR, Young DB: A novel approach to identification of T cell epitopes in Mycobacterium tuberculosis using human T lymphocyte clones. Immunology 1987; 60: 1–5.PubMedGoogle Scholar
  16. 16.
    Mehra V, Brennen PJ, Rada E, et al: Lymphocyte suppression in leprosy induced by unique M. leprae glycolipid. Nature 1984; 308: 194–196.PubMedCrossRefGoogle Scholar
  17. 17.
    Mehra V, Convit J, Rubinstein A, Bloom BR: Activated suppressor T cells in leprosy. J Immunol 1982; 129: 1946–1951.PubMedGoogle Scholar
  18. 18.
    Mehra V, Mason LH, Fields JP, Bloom BR: Lepromin-induced supressor cells in patients with leprosy. J Immunol 1979; 123: 1813–1817.PubMedGoogle Scholar
  19. 19.
    Mehra V, Mason LH, Rothman W, et al: Delineation of a human T cell subset responsible for lepromin-induced suppression in leprosy patients. J Immunol 1980; 125: 1183–1188.PubMedGoogle Scholar
  20. 20.
    Mehra V, Sweetser D, Young RA: Efficient mapping of protein antigenic determinants. Proc Natl Acad Sei USA 1986; 83: 7013–7017.CrossRefGoogle Scholar
  21. 20.
    Mehra V, Sweetser D, Young RA: Efficient mapping of protein antigenic determinants. Proc Natl Acad Sei USA 1986; 83: 7013–7017.CrossRefGoogle Scholar
  22. 22.
    Modlin RL, Brenner MB, Krangel MS, et al: T-cell receptors of human suppressor cells. Nature 1987; 329: 541–545.PubMedCrossRefGoogle Scholar
  23. 23.
    Modlin RL, Kato H, Mehra V, et al: Genetically restricted suppressor T-cell clones derived from lepromatous leprosy lesions. Nature 1986; 322: 459–461.PubMedCrossRefGoogle Scholar
  24. 24.
    Modlin RL, Mehra V, Wong L, et al: Suppressor T lymphocytes from lepromatous leprosy skin lesions. J Immunol 1986; 137: 2831–2834.PubMedGoogle Scholar
  25. 25.
    Mustafa AS, Gill HK, Nerland A, et al: Human T-cell clones recognize a major M. leprae protein antigen expressed in E. coli. Nature 1986; 319: 63–66.Google Scholar
  26. 26.
    Mustafa AS, Oftung F, Deggerdal A, et al: Gene isolation with human T lymphocyte probes. J Immunol 1988; 141: 2729–2733.PubMedGoogle Scholar
  27. 27.
    Nath I, van Rood JJ, Mehra NK, Vaidya MC: Natural suppressor cells in human leprosy: the role of HLA-D-identical peripheral lymphocytes and macrophages in the in vitro modulation of lymphoproliferative responses. Clin Exp Immunol 1980; 42: 203–210.PubMedGoogle Scholar
  28. 28.
    Ottenhoff THM, Elferink DG, Klaster PR, de Vries RRP: Cloned suppressor T cells from a lepromatous leprosy patient suppress Mycobacterium leprae reactive helper T cells. Nature 1986; 322: 462–464.PubMedCrossRefGoogle Scholar
  29. 29.
    Ottenhoff THM, Klatser PR, Ivanyi J, et al: Mycobacterium leprae-specific protein antigens defined by cloned human helper T cells. Nature 1986; 319: 66–68.PubMedCrossRefGoogle Scholar
  30. 30.
    Salgame PR, Colston MJ, Mitchison NA: Murine T-cell reactivity to cloned Mycobacterium leprae antigens. Lepr Rev 1986; 57 (suppl 2): 301–304.PubMedGoogle Scholar
  31. 31.
    Stoner GL, Touw J, Belehu A, Naafs B: In vitro lymphoproliferative response to Mycobacterium leprae of HLA-D identical siblings of lepromatous leprosy patients. Lancet 1978; 2: 543–547.PubMedCrossRefGoogle Scholar
  32. 32.
    Young RA, Mehra V, Sweetser D, et al: Genes for the major protein antigens of M. leprae. Nature 1985; 316: 450–452.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag New York Inc. 1989

Authors and Affiliations

  • Vijay Mehra
  • Robert L. Modlin
  • Thomas H. Rea
  • William R. Jacobs
  • Scott B. Snapper
  • Jacinto Convit
  • Barry R. Bloom

There are no affiliations available

Personalised recommendations